Why Attend

Heart failure management is changing rapidly. The primary goal of the 32nd Annual San Diego Summer Heart Failure Symposium is to provide a comprehensive overview of advances in our understanding of the causes of heart failure and the best approaches for treating this disease in its varying forms. To accomplish this, we have assembled an exciting program that combines a series of focused lectures, case discussions and Q & A sessions that will help bring practicing clinicians up to date on the best approaches for treating their patients.

At the conclusion of this program, the participant should be able to:

1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.

2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.

3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure

Location

This meeting will be held at the Hilton La Jolla Torrey Pines.

10950 N Torrey Pines Rd

La Jolla, CA

Why Attend

Heart failure management is changing rapidly. The primary goal of the 32nd Annual San Diego Summer Heart Failure Symposium is to provide a comprehensive overview of advances in our understanding of the causes of heart failure and the best approaches for treating this disease in its varying forms. To accomplish this, we have assembled an exciting program that combines a series of focused lectures, case discussions and Q & A sessions that will help bring practicing clinicians up to date on the best approaches for treating their patients.

At the conclusion of this program, the participant should be able to:

1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.

2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.

3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure

Location

This meeting will be held at the Hilton La Jolla Torrey Pines.

10950 N Torrey Pines Rd

La Jolla, CA

A CME Symposium during the 2026 San Diego Heart Failure Summer Symposium in San Diego, California.

AGENDA

3:55 PM           ATTR-CM: Epidemiology, Clinical Clues, and Diagnosis
                         Ronald Witteles, MD

4:10 PM            ATTR-CM Management: Focus on Disease-Modifying Therapies, HF Therapies, and Future Directions
                          Ahmad Masri, MD, MS

4:30 PM            Case Presentation: Optimization of ATTR-CM Management with Patient-Centered Care
                          Moderator: Marcus Anthony Urey, MD
                          Panelists: Ahmad Masri, MD, MS; Ronald Witteles, MD

4:50 PM            Question and Answer

EDUCATIONAL OBJECTIVES

■  Identify clinical clues that suggest the possibility for an ATTR-CM diagnosis.

■  Explain key steps in the diagnostic algorithm for ATTR-CM.

■  Describe the clinical evidence for ATTR-CM disease-modifying therapies, best adjustments of HF GDMT in patients with ATTR-CM, and novel therapies
in development.

Educational Grant

This activity is supported by an independent educational grant from Alnylam Pharmaceuticals, Inc. and BridgeBio.

CHAIR

Marcus Anthony Urey, MD
Associate Professor of Medicine
UC San Diego Health
San Diego, California

FACULTY

Ahmad Masri, MD, MS
Associate Professor of Medicine
Oregon Health & Science University
Portland, Oregon

Ronald Witteles, MD
Professor of Medicine (Cardiovascular Medicine)
Stanford University School of Medicine
Stanford, California

Why Attend

Heart failure management is changing rapidly. The primary goal of the 32nd Annual San Diego Summer Heart Failure Symposium is to provide a comprehensive overview of advances in our understanding of the causes of heart failure and the best approaches for treating this disease in its varying forms. To accomplish this, we have assembled an exciting program that combines a series of focused lectures, case discussions and Q & A sessions that will help bring practicing clinicians up to date on the best approaches for treating their patients.

At the conclusion of this program, the participant should be able to:

1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.

2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.

3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure

Location

This meeting will be held at the Hilton La Jolla Torrey Pines.

10950 N Torrey Pines Rd

La Jolla, CA

About the 2026 HFM

The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. The University of North Carolina (UNC) Heart Failure Conference is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.

Why You Should Attend

• Speakers are recognized experts in their field
• Cutting-edge review of key clinical trial results on novel therapies
• Case-Based decision making on advanced therapies and EP approaches to CHF patients
• Earn up to 17.75 Continuing Education Credits

Location

The meeting will be held at the Omni Amelia Island Resort.

39 Beach Lagoon Rd

Fernandina Beach, FL

The Omni Amelia Island is Florida’s premier AAA-Four Diamond facility. Located on Amelia Island, Florida, just 29 miles north of Jacksonville International Airport (JAX), the property is easily accessible by air and road and offers a variety of accommodations and excellent meeting facilities.

A CME Symposium during the 2026 Heart Failure Management Conference in Fernandina Beach, Florida.

AGENDA

12:15 pm                  Introduction
                                 Javed Butler, MD, MPH, MBA (Chair)

12:20 pm                 Aldosterone Pathophysiology, MRAs, and Outcomes in HFrEF
                                 Javed Butler, MD, MPH, MBA

12:35 pm                 MRAs in HFmrEF and HFpEF: New Opportunities to Improve Patient Outcomes
                                 Muthiah Vaduganathan, MD, MPH

12:50 pm                 Case Presentation: HFpEF—From Diagnosis to Optimal Patient Care
                                 Presenter: Stephen Greene, MD

Panelists:                Javed Butler, MD, MPH, MBA; Muthiah Vaduganathan, MD, MPH;
                                 Orly Vardeny, PharmD, MS

1:05 pm                   Question-and-Answer

EDUCATIONAL OBJECTIVES

• Describe the mechanisms of action of mineralocorticoid receptor antagonists
(MRAs)
• Discuss the evidence for steroidal MRAs (sMRAs) in HFrEF and the challenges
associated with their use
• Explain similarities and differences between nonsteroidal MRAs (nsMRAs) and
sMRAs
• Interpret the clinical trial evidence for sMRAs and nsMRAs in patients with
HFmrEF and HFpEF
                                                                                                     • Indicate best practices for the diagnosis and treatment of patients with HFpEF

Educational Grant

This activity is supported by an independent educational grant from Bayer.

CHAIR

Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina

FACULTY

Muthiah Vaduganathan, MD, MPH
Co-Director, Center for Cardiometabolic Implementation Science
Assistant Professor of Medicine
Mass General Brigham and Harvard Medical School
Boston, Massachusetts

Orly Vardeny, PharmD, MS
Minneapolis VA Center for Care Delivery and Outcomes Research
Professor of Medicine
University of Minnesota
Minneapolis, Minnesota

About the 2026 HFM

The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. The University of North Carolina (UNC) Heart Failure Conference is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.

Why You Should Attend

• Speakers are recognized experts in their field
• Cutting-edge review of key clinical trial results on novel therapies
• Case-Based decision making on advanced therapies and EP approaches to CHF patients
• Earn up to 17.75 Continuing Education Credits

Location

The meeting will be held at the Omni Amelia Island Resort.

39 Beach Lagoon Rd

Fernandina Beach, FL

The Omni Amelia Island is Florida’s premier AAA-Four Diamond facility. Located on Amelia Island, Florida, just 29 miles north of Jacksonville International Airport (JAX), the property is easily accessible by air and road and offers a variety of accommodations and excellent meeting facilities.

About the 2026 HFM

The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. The University of North Carolina (UNC) Heart Failure Conference is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.

Why You Should Attend

• Speakers are recognized experts in their field
• Cutting-edge review of key clinical trial results on novel therapies
• Case-Based decision making on advanced therapies and EP approaches to CHF patients
• Earn up to 17.75 Continuing Education Credits

Location

The meeting will be held at the Omni Amelia Island Resort.

39 Beach Lagoon Rd

Fernandina Beach, FL

The Omni Amelia Island is Florida’s premier AAA-Four Diamond facility. Located on Amelia Island, Florida, just 29 miles north of Jacksonville International Airport (JAX), the property is easily accessible by air and road and offers a variety of accommodations and excellent meeting facilities.

A CME Symposium during the 2026 Heart Failure Management Conference in Fernandina Beach, Florida.

AGENDA

8:00 am                          Introduction
                                       Muthiah Vaduganathan, MD, MPH (Chair)

8:05 am                          Hyperkalemia and Heart Failure: Impact of Continuation/Discontinuation of RAASi Therapy
                                       Akshay Desai, MD, MPH

8:20 am                          Treating Hyperkalemia and Optimizing RAASi in HF Patients with Potassium Binders
                                       Muthiah Vaduganathan, MD, MPH

8:35 am                          Best Strategies for Managing My HFrEF Patient with Elevated Potassium and a History of Hyperkalemia
                                       Case Presenter: Robert Page, PharmD, MSPH, BCPS, BCGP
                                       Panelists: Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC; Akshay Desai, MD, MPH; Muthiah Vaduganathan, MD, MPH

8:50 am                          Question-and-Answer

EDUCATIONAL OBJECTIVES

•  Recognize heart failure patients at risk for developing hyperkalemia

•  Describe the relationship between hyperkalemia, suboptimal RAASi therapy and poor clinical outcomes

•  Explain the data with, and demonstrate prudent use of novel potassium binders

Educational Grant

Voxmedia International gratefully acknowledges the educational grant provided by AstraZeneca Pharmaceuticals.

CHAIR

Muthiah Vaduganathan, MD, MPH
Co-Director, Center for Cardiometabolic Implementation Science
Assistant Professor of Medicine
Mass General Brigham and Harvard Medical School
Boston, Massachusetts

FACULTY

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC
Associate Chief Nursing Officer--Research and Innovation
Clinical Nurse Specialist--Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Akshay Desai, MD, MPH
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Robert Page, PharmD, MSPH, BCPS, BCGP
Professor, Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado

A CME Symposium during the 2026 Heart Failure Management Conference in Fernandina Beach, Florida.

AGENDA

12:30 PM                       Introduction
                                      Mathew Maurer, MD (Chair)

12:35 PM                      Suspecting and Diagnosing Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
                                      Jan Griffin, MD

12:50 PM                      Best Practices for Managing Patients with HF and ATTR-CM
                                      Mathew Maurer, MD

1:10 PM                         Individualized Management of the ATTR-CM Patient with HF
                                      Case Presenter: Frederick Ruberg, MD
                                      Panelists: Jan Griffin, MD; Mathew Maurer, MD

1:25 PM                        Question and Answer

EDUCATIONAL OBJECTIVES

- Recognize the cardiac and extracardiac red fl ags which raise suspicion for ATTR-CM.

- Describe the diagnostic testing components to quickly and accurately diagnose ATTR-CM.

- Summarize current recommendations for use of HF GDMT in ATTR-CM patients and the evolving evidence for Silencers and Stabilizers for ATTR-CM.

- Identify the recommended parameters for monitoring disease progression in ATTR-CM.

Educational Grant

This activity is supported by an independent educational grant from Alnylam Pharmaceuticals, Inc. and BridgeBio.

CHAIR

Mathew Maurer, MD
Arnold and Arlene Goldstein Professor of Cardiology
Professor of Medicine
Columbia University Irving Medical Center
Vagelos College of Physicians & Surgeons
New York, New York

FACULTY

Jan Griffin, MD
Associate Professor of Medicine
Medical University of South Carolina
Charleston, South Carolina

Frederick Ruberg, MD
Thomas J. Ryan Professor of Cardiovascular Medicine
Chief, Cardiovascular Medicine
Professor of Radiology
Boston University Chobanian & Avedisian School of Medicine
Boston Medical Center
Boston, Massachusetts

About the 2026 HFM

The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well established evidence-based standards of care. The University of North Carolina (UNC) Heart Failure Conference is designed to provide a comprehensive overview of the current strategies for the treatment of heart failure. Course faculty will review cutting-edge approaches to diagnosis and classification and provide techniques and tips for the pharmacological and device management of heart failure. The material presented will have an interdisciplinary focus and will be of interest to physicians and other health care professionals who care for patients with heart failure.

Why You Should Attend

• Speakers are recognized experts in their field
• Cutting-edge review of key clinical trial results on novel therapies
• Case-Based decision making on advanced therapies and EP approaches to CHF patients
• Earn up to 17.75 Continuing Education Credits

Location

The meeting will be held at the Omni Amelia Island Resort.

39 Beach Lagoon Rd

Fernandina Beach, FL

The Omni Amelia Island is Florida’s premier AAA-Four Diamond facility. Located on Amelia Island, Florida, just 29 miles north of Jacksonville International Airport (JAX), the property is easily accessible by air and road and offers a variety of accommodations and excellent meeting facilities.